✦ LIBER ✦

POD-07.08 Morbidity of High Intensity Focused Ultrasound (HIFU) as a Primary Monotherapy for Low-Risk Localized Prostate Cancer: Outcomes from the ENLIGHT Trial

✍ Scribed by C.N. Robertson; A. Sliwinski; J. Delisio; E. Wallen; J.F. Ward; W. Orovan; D. Locke; E.D. Crawford; P. Maroni; R. Donnell; I. Grunberger; R. Bevan-Thomas; R. Munver; I. Sawczuk; S. Chang; I.S. Gill

Book ID: 116954390
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 132 KB
Volume: 78
Category: Article
ISSN: 0090-4295
DOI: 10.1016/j.urology.2011.07.458

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1206 BIOCHEMICAL SURVIVAL AND MORBIDITY

1206 BIOCHEMICAL SURVIVAL AND MORBIDITY OF HIGH INTENSITY FOCUSED ULTRASOUND (HIFU) AS A PRIMARY MONOTHERAPY FOR LOW-RISK LOCALIZED PROSTATE CANCER: OUTCOMES FROM THE @–REGISTRY FOLLOWING THE ENLIGHT TRIAL INCLUSION CRITERIA

✍ Ward, John; Robertson, Cary; Crouzet, Sebastien; Brown, Stephen; Berge, Viktor; 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 52 KB

1004 10 YEAR OUTCOME AND MORBIDITY OF HI

1004 10 YEAR OUTCOME AND MORBIDITY OF HIGH-INTENSITY FOCUSSED ULTRASOUND (HIFU) AS A PRIMARY THERAPY FOR LOCALIZED PROSTATE CANCER: OUTCOMES FROM 2552 MEN FOLLOWED WITH THE @-REGISTRY

✍ Ganzer, Roman; Paulesu, Antonell; Berge, Viktor; Blana, Andreas; Brown, Stephen; 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 42 KB